InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44
United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Theodore Alan Huizenga
2 Jan 2024
SVP, Chief Accounting Officer
Exercised, kept
3,000
$21.00
$63.00K
Theodore Alan Huizenga
9 May 2023
SVP, Chief Accounting Officer
Exercised, kept
3,000
$21.00
$63.00K
Matthew K Fust
4 Mar 2022
Director
Exercised, kept
7,500
$40.37
$302.78K
Thomas Richard Kassberg
30 Sep 2021
Cbo & EVP
Exercised, kept
109,734
$0.31
$34.02K
Emil D Kakkis
12 Mar 2020
President & CEO
Exercised, kept
66,533
$3.01
$200.00K
Emil D Kakkis
12 Mar 2020
President & CEO
Exercised, kept
83,167
$3.01
$250.00K
Shalini Sharp
16 Sep 2019
CFO & Executive Vice President
Exercised, kept
24,880
$6.86
$170.68K
Shalini Sharp
16 Sep 2019
CFO & Executive Vice President
Exercised, kept
6,963
$0.81
$5.64K
Theodore Alan Huizenga
2 Jan 2019
VP, Controller and PAO
Exercised, kept
2,448
$21.00
$51.41K
Shalini Sharp
31 Oct 2018
CFO & Executive Vice President
Exercised, kept
12,000
$0.82
$9.78K
William Aliski
23 Jan 2018
Director
Exercised, kept
11,500
$21.00
$241.50K
Shalini Sharp
23 Dec 2016
CFO & Executive Vice President
Exercised, kept
6,500
$0.81
$5.27K
Show all 249 transactions →

What was left out

Form 4 filings counted 449
Amendments (4/A) skipped 11
Filings about a different issuer 3
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 28
Sales straight out of an exercise 57
Sales at will 149
Transactions with no price 0
Shares from compensation/vesting 3,103,818
Sales filed before the plan box existed 100
History held since 3 Feb 2014